Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:41
Strong to severe storms possible Wednesday as dangerous heat...
-
4:28
🐶🎤Still wondering who let the dogs out? Baha Men head to...
-
4:02
Festival season gets into full swing in Milwaukee
-
2:49
Milwaukee’s Lincoln Avenue School severely damaged in overnight...
-
1:45
CBS 58’s Hometown Athlete: A Marquette homecoming
-
1:47
Milwaukee food truck owners experience extreme heat in trucks
-
1:40
‘We’re out here burning up’: Multiple Milwaukee County...
-
0:40
AG Kaul calls birthright citizenship ruling a victory; GOP lawmakers...
-
2:11
Conservation projects face uncertainty after Knowles-Nelson program...
-
2:04
Families speak out after ICE detentions in Milwaukee; city weighs...
-
1:56
Lincoln Avenue School fire forces summer meal site change
-
1:48
Bob Uecker mural in downtown Milwaukee unveiled with tailgate-themed...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.